Medical Devices Brazil

Brazil Hormone Testing at Home Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Brazil Hormone Testing at Home Market Industry Trends and Forecast to 2034: Segmented by (Hormone, Sample, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Brazil · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $19.8 Mn Placeholder estimate
Estimate 2025 $21.9 Mn 2.6% of the global market
Projected 2034 $54.8 Mn 149.6% Adds $32.8 Mn over 9 forecast years
CAGR 2025–2034 10.7% Faster than 58% of 173 Medical Devices markets here
Key players 5 Companies profiled
  • Brazil is 2.59% of the global market.
  • In Latin America, the largest is Brazil (this report) at $21.9 Mn.
  • Fastest growing: Ecuador at 11% a year.
  • Brazil ranks 1st of 3 by size in Latin America.

Market size projection

Brazil

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$32.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Hormone Testing at Home Market market size by year, Brazil
YearMarket sizeChange that yearSince 2025
2024 (estimate) $19.8 Mn — —
2025 (base) $21.9 Mn +$2.1 Mn —
2026 (forecast) $24.3 Mn +$2.3 Mn +10.7%
2027 (forecast) $26.9 Mn +$2.6 Mn +22.5%
2028 (forecast) $29.8 Mn +$2.9 Mn +35.7%
2029 (forecast) $32.9 Mn +$3.2 Mn +50.2%
2030 (forecast) $36.5 Mn +$3.5 Mn +66.2%
2031 (forecast) $40.4 Mn +$3.9 Mn +84%
2032 (forecast) $44.7 Mn +$4.3 Mn +103.7%
2033 (forecast) $49.5 Mn +$4.8 Mn +125.5%
2034 (forecast) $54.8 Mn +$5.3 Mn +149.6%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Brazil Hormone Testing at Home Market Analysis at a glance
Market size, 2025$21.9 Mn placeholder estimate
Forecast, 2034$54.8 Mn placeholder estimate
Growth (CAGR), 2025–203410.7% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsHormone, sample and end user (see all)
Key playersEverlywell, LetsGetChecked, Thorne, Mira, Hims & Hers Health (see all)
Regulator in BrazilANVISASource: ANVISA. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Brazil Hormone Testing at Home Market Analysis Executive Summary

At-home hormone tests measure hormones such as estrogen, thyroid, cortisol and testosterone from finger-prick blood or saliva.

Key segments of the hormone Testing at Home market include hormone (Female Sex Hormones, Thyroid and Cortisol) and sample (Blood, Saliva and Urine).

Bar chart: Brazil Hormone Testing at Home market size, 2024–2034, placeholder estimates. $19.8 Mn in 2024, $21.9 Mn in 2025 and $54.8 Mn in 2034, 10.7% CAGR.
Brazil Hormone Testing at Home market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Brazil Hormone Testing at Home Market Dynamics

Market Growth Drivers

Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.

Opportunity

Femtech, personalised care and new treatments for under-served conditions open strong growth for the hormone Testing at Home market, especially as employers and payers add women's health benefits.

Market Restraints

Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the hormone Testing at Home market.

Competitive Landscape for Hormone Testing at Home Market in Brazil

The hormone Testing at Home market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Hormone Testing at Home Market in Brazil

Hormone Testing at Home in Brazil: rules and payment

Medical devices are notified to or registered with ANVISA, the National Health Surveillance Agency, depending on their risk class.⁠[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.⁠[2]

[1] ANVISA. Checked 14 Nov 2026.

[2] CONITEC. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how hormone Testing at Home products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in Brazil.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Hormone Testing at Home right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Hormone Testing at Home in context

Brazil compared

  • Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 4 countries we cover in Latin America.[1]
  • Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 4 countries we cover in Latin America.[2]
  • People aged 65 and over: 11.5% of people (2025). World: 10.4% of people (2025). Highest of the 4 countries we cover in Latin America.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 16 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 17 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 17 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Hormone Testing at Home market in Brazil?
Placeholder estimate: about $21.9 Mn in 2025, rising to about $54.8 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Hormone Testing at Home market in Brazil growing?
Placeholder estimate: about 10.7% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Hormone Testing at Home market report cover?
The report splits the market by hormone (Female Sex Hormones, Thyroid, Cortisol, Testosterone), sample (Blood, Saliva, Urine) and end user (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Home Care Settings).
Who are the key players in the Hormone Testing at Home market?
Key players include Everlywell, LetsGetChecked, Thorne, Mira and Hims & Hers Health.
What is driving the Hormone Testing at Home market?
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the hormone Testing at Home market. New products designed around women's biology and digital care are improving access.
Who regulates Hormone Testing at Home in Brazil?
Medical devices are notified to or registered with ANVISA, the National Health Surveillance Agency, depending on their risk class. Source: ANVISA. Checked 14 Nov 2026.
How is healthcare paid for in Brazil?
The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds. Source: CONITEC. Checked 14 Nov 2026.
Back to Catalogue

Related Medical Devices reports in Brazil

See all

Related on women's health and diagnostics and lab testing

See the topic